纵横研报
Ticker Detail

688293.SHG

¥53.95+5.78% 奥浦迈 Biotechnology
00Reports China 医疗健康
Shanghai OPM Biosciences Co. Ltd. A
医疗健康 · 生物科技

Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers cell culture media and feed supplements, such as OPM's CHO-Platform, OPM-293 Platform, and VegaCHO media and feeds, as well as customized cell culture media development services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development, cell banking, upstream process development, downstream process development, formulation development, and quality control and product characterization of biologics. The company was founded in 2013 and is headquartered in Shanghai, China.

MARKET 市值 6.88B CNY PE 156.1x 52W ¥33.97 – ¥67.49 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 117.7% ROE 2.6% 营业利润率 4.4% 净利润率 14.6%
ANALYST 股息率 1.00%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制